首页 > 最新文献

Movement Disorders最新文献

英文 中文
Genetics and Metabolic Diseases 遗传学与代谢疾病
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-27 DOI: 10.1002/mds.29955
{"title":"Genetics and Metabolic Diseases","authors":"","doi":"10.1002/mds.29955","DOIUrl":"https://doi.org/10.1002/mds.29955","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"39 S1","pages":"S740-S808"},"PeriodicalIF":7.4,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mds.29955","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142324706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physiology 生理学
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-27 DOI: 10.1002/mds.29956
{"title":"Physiology","authors":"","doi":"10.1002/mds.29956","DOIUrl":"https://doi.org/10.1002/mds.29956","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"39 S1","pages":"S809-S858"},"PeriodicalIF":7.4,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mds.29956","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142324707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parkinsonisms 帕金森症
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-27 DOI: 10.1002/mds.29946
{"title":"Parkinsonisms","authors":"","doi":"10.1002/mds.29946","DOIUrl":"https://doi.org/10.1002/mds.29946","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"39 S1","pages":"S1-S99"},"PeriodicalIF":7.4,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mds.29946","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142324554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognition and Psychiatric Disturbances 认知和精神障碍
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-27 DOI: 10.1002/mds.29947
{"title":"Cognition and Psychiatric Disturbances","authors":"","doi":"10.1002/mds.29947","DOIUrl":"https://doi.org/10.1002/mds.29947","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"39 S1","pages":"S100-S198"},"PeriodicalIF":7.4,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mds.29947","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142324555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substantiating the Short Burst Duration in Cortical Myoclonus. 证实皮层肌阵挛的短爆发持续时间
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-24 DOI: 10.1002/mds.29990
Sterre van der Veen, Amber Maliepaard, Madelein van der Stouwe, Jelle Dalenberg, Inge Tuitert, Jan Willem J Elting, Marina A J Tijssen

Background: Myoclonus is characterized by involuntary, shock-like movements, of which cortical (CM) and non-cortical myoclonus (NCM) are most common. Electrophysiology can help differentiate between these subtypes; however, the diagnostic value of several features is largely unknown.

Objective: This study aims to determine the diagnostic value of the burst duration in distinguishing CM and NCM.

Methods: We manually identified the burst duration of 8 patients with CM, confirmed by electromyography-electroencephalography registration or somatosensory-evoked potentials, and 19 patients with NCM, suspected due to a myoclonus-dystonia phenotype (MYC/DYT-SGCE positive and negative).

Results: The sensitivity and specificity were calculated to assess the diagnostic value. The burst duration of CM (31.1 ms) was significantly shorter than that of NCM (56.7 ms), with a sensitivity of 100% and a specificity of 89.5% at a threshold of 45.0 ms. A minimum of 10 randomly selected bursts were sufficient for reliable diagnostic accuracy.

Conclusion: The burst duration seems a valuable supportive diagnostic criterion for distinguishing CM and NCM. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

背景:肌阵挛的特征是不自主的冲击样运动,其中皮质肌阵挛(CM)和非皮质肌阵挛(NCM)最为常见。电生理学有助于区分这些亚型;然而,一些特征的诊断价值在很大程度上还不为人所知:本研究旨在确定爆发持续时间在区分 CM 和 NCM 方面的诊断价值:方法:我们对 8 名经肌电图-脑电图登记或体感诱发电位证实的 CM 患者和 19 名因肌阵挛-肌张力障碍表型(MYC/DYT-SGCE 阳性和阴性)而被怀疑的 NCM 患者的爆发持续时间进行了人工鉴定:计算灵敏度和特异性以评估诊断价值。在阈值为 45.0 毫秒时,CM 的爆发持续时间(31.1 毫秒)明显短于 NCM(56.7 毫秒),灵敏度为 100%,特异性为 89.5%。至少 10 次随机选择的脉冲串足以获得可靠的诊断准确性:结论:脉冲串持续时间似乎是区分 CM 和 NCM 的重要辅助诊断标准。© 2024 The Author(s).运动障碍》由 Wiley Periodicals LLC 代表国际帕金森和运动障碍协会出版。
{"title":"Substantiating the Short Burst Duration in Cortical Myoclonus.","authors":"Sterre van der Veen, Amber Maliepaard, Madelein van der Stouwe, Jelle Dalenberg, Inge Tuitert, Jan Willem J Elting, Marina A J Tijssen","doi":"10.1002/mds.29990","DOIUrl":"https://doi.org/10.1002/mds.29990","url":null,"abstract":"<p><strong>Background: </strong>Myoclonus is characterized by involuntary, shock-like movements, of which cortical (CM) and non-cortical myoclonus (NCM) are most common. Electrophysiology can help differentiate between these subtypes; however, the diagnostic value of several features is largely unknown.</p><p><strong>Objective: </strong>This study aims to determine the diagnostic value of the burst duration in distinguishing CM and NCM.</p><p><strong>Methods: </strong>We manually identified the burst duration of 8 patients with CM, confirmed by electromyography-electroencephalography registration or somatosensory-evoked potentials, and 19 patients with NCM, suspected due to a myoclonus-dystonia phenotype (MYC/DYT-SGCE positive and negative).</p><p><strong>Results: </strong>The sensitivity and specificity were calculated to assess the diagnostic value. The burst duration of CM (31.1 ms) was significantly shorter than that of NCM (56.7 ms), with a sensitivity of 100% and a specificity of 89.5% at a threshold of 45.0 ms. A minimum of 10 randomly selected bursts were sufficient for reliable diagnostic accuracy.</p><p><strong>Conclusion: </strong>The burst duration seems a valuable supportive diagnostic criterion for distinguishing CM and NCM. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p>","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":" ","pages":""},"PeriodicalIF":7.4,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142306806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells - A PROSPAX study. PBMC 中的 Sacsin 水平:外周血细胞中 SACS 变体的诊断测定--PROSPAX 研究。
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-24 DOI: 10.1002/mds.30012
Ceren Tunca, Eylül Ece İşlek Camadan, Natalia Smolina, Robin J Palvadeau, Özgür Öztop Çakmak, Atay Vural, Andreas Traschütz, Filippo M Santorelli, Bernard Brais, Rebecca Schüle, Matthis Synofzik, A Nazlı Başak

Background: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a common recessive ataxia that is still underdiagnosed worldwide. An easily accessible diagnostic biomarker might help to diagnostically confirm patients presenting SACS variants of unknown significance (VUS) or atypical phenotypes.

Objectives: To detect sacsin in peripheral blood mononuclear cells (PBMCs) and to validate its diagnostic biomarker quality to discriminate biallelic SACS patients (including patients with VUS and/or atypical phenotypes) against healthy controls, non-ARSACS spastic ataxia patients, and heterozygous SACS carriers.

Methods: Sacsin protein levels in PBMCs were assessed in patients versus controls and validated in skin-derived fibroblasts.

Results: Patients with biallelic SACS variants - including patients with VUS and/or atypical phenotypes - showed loss of sacsin in PBMCs, with discriminative performance against healthy, heterozygous, and non-ARSACS controls. This included all investigated SACS missense variants. Also, C-terminal variants escaping nonsense-mediated decay, while not differing from controls in expression level, showed lower molecular weight in this assay.

Conclusions: Assessing sacsin levels using PBMCs offers an easy, peripherally accessible diagnostic biomarker for ARSACS, with PBMCs being much less invasive and easier to handle than fibroblasts. Additionally, this might be a potential target-engagement blood biomarker for sacsin-increasing therapies. © 2024 International Parkinson and Movement Disorder Society.

背景:沙勒沃瓦-萨盖内常染色体隐性痉挛性共济失调症(ARSACS)是一种常见的隐性共济失调症,在全球范围内仍未得到充分诊断。一种易于获得的诊断生物标志物可能有助于诊断确认出现意义不明变异(VUS)或非典型性表型的 SACS 患者:目的:检测外周血单核细胞(PBMCs)中的sacsin,并验证其诊断生物标志物的质量,以区分双倍拷贝SACS患者(包括VUS和/或非典型表型患者)与健康对照组、非ARSACS痉挛性共济失调患者和杂合子SACS携带者:方法:评估患者与对照组 PBMC 中的 Sacsin 蛋白水平,并在皮肤成纤维细胞中进行验证:结果:双偶SACS变异体患者(包括VUS和/或非典型性表型患者)的PBMCs中的Sacsin水平下降,与健康、杂合子和非SACS对照组相比具有鉴别力。这包括所有研究过的 SACS 错义变体。此外,C端变异体逃脱了无义介导的衰变,虽然在表达水平上与对照组没有差异,但在该检测中显示出较低的分子量:结论:使用 PBMCs 评估糖蛋白水平为 ARSACS 提供了一种简便、外周可及的诊断生物标志物,与成纤维细胞相比,PBMCs 侵袭性更小,更易于处理。此外,这也可能成为增加糖蛋白疗法的潜在靶向参与血液生物标志物。© 2024 国际帕金森和运动障碍协会。
{"title":"Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells - A PROSPAX study.","authors":"Ceren Tunca, Eylül Ece İşlek Camadan, Natalia Smolina, Robin J Palvadeau, Özgür Öztop Çakmak, Atay Vural, Andreas Traschütz, Filippo M Santorelli, Bernard Brais, Rebecca Schüle, Matthis Synofzik, A Nazlı Başak","doi":"10.1002/mds.30012","DOIUrl":"https://doi.org/10.1002/mds.30012","url":null,"abstract":"<p><strong>Background: </strong>Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a common recessive ataxia that is still underdiagnosed worldwide. An easily accessible diagnostic biomarker might help to diagnostically confirm patients presenting SACS variants of unknown significance (VUS) or atypical phenotypes.</p><p><strong>Objectives: </strong>To detect sacsin in peripheral blood mononuclear cells (PBMCs) and to validate its diagnostic biomarker quality to discriminate biallelic SACS patients (including patients with VUS and/or atypical phenotypes) against healthy controls, non-ARSACS spastic ataxia patients, and heterozygous SACS carriers.</p><p><strong>Methods: </strong>Sacsin protein levels in PBMCs were assessed in patients versus controls and validated in skin-derived fibroblasts.</p><p><strong>Results: </strong>Patients with biallelic SACS variants - including patients with VUS and/or atypical phenotypes - showed loss of sacsin in PBMCs, with discriminative performance against healthy, heterozygous, and non-ARSACS controls. This included all investigated SACS missense variants. Also, C-terminal variants escaping nonsense-mediated decay, while not differing from controls in expression level, showed lower molecular weight in this assay.</p><p><strong>Conclusions: </strong>Assessing sacsin levels using PBMCs offers an easy, peripherally accessible diagnostic biomarker for ARSACS, with PBMCs being much less invasive and easier to handle than fibroblasts. Additionally, this might be a potential target-engagement blood biomarker for sacsin-increasing therapies. © 2024 International Parkinson and Movement Disorder Society.</p>","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":" ","pages":""},"PeriodicalIF":7.4,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142306805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confirmation of RAB32 Ser71Arg Involvement in Parkinson's Disease. 证实 RAB32 Ser71Arg 与帕金森病有关。
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-23 DOI: 10.1002/mds.30024
Guillaume Cogan, Christelle Tesson, Christine Brefel-Courbon, Aymeric Lanore, Gatepe Cedoine Kodjovi, Lisa Welment, Fabienne Clot, Suzanne Lesage, Alexis Brice
{"title":"Confirmation of RAB32 Ser71Arg Involvement in Parkinson's Disease.","authors":"Guillaume Cogan, Christelle Tesson, Christine Brefel-Courbon, Aymeric Lanore, Gatepe Cedoine Kodjovi, Lisa Welment, Fabienne Clot, Suzanne Lesage, Alexis Brice","doi":"10.1002/mds.30024","DOIUrl":"https://doi.org/10.1002/mds.30024","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":" ","pages":""},"PeriodicalIF":7.4,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142277685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome. 对进行性核上性麻痹和皮质基底综合征脑脊液α-突触核蛋白种子扩增测定的评估
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-20 DOI: 10.1002/mds.30019
David P Vaughan,Riona Fumi,Marte Theilmann Jensen,Megan Hodgson,Tatiana Georgiades,Lesley Wu,Danielle Lux,Ruth Obrocki,Jennifer Lamoureux,Olaf Ansorge,Kieren S J Allinson,Thomas T Warner,Zane Jaunmuktane,Anjum Misbahuddin,P Nigel Leigh,Boyd C P Ghosh,Kailash P Bhatia,Alistair Church,Christopher Kobylecki,Michele T M Hu,James B Rowe,Cornelis Blauwendraat,Huw R Morris,Edwin Jabbari
BACKGROUNDSeed amplification assay (SAA) testing has been developed as a biomarker for the diagnosis of α-synuclein-related neurodegenerative disorders.OBJECTIVEThe objective of this study was to assess the rate of α-synuclein SAA positivity in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) and to analyze clinical and pathological features of SAA-positive and -negative cases.METHODSA total of 96 cerebrospinal fluid samples from clinically diagnosed PSP (n = 59) and CBS (n = 37) cases were analyzed using α-synuclein SAA.RESULTSSix of 59 (10.2%) PSP cases were α-synuclein SAA positive, including one case who was MSA-type positive. An exploratory analysis showed that PSP cases who were Parkinson's disease-type positive were older and had a shorter disease duration compared with SAA-negative cases. In contrast, 11 of 37 (29.7%) CBS cases were α-synuclein SAA positive, including two cases who were MSA-type positive.CONCLUSIONSOur results suggest that α-synuclein seeds can be detected in PSP and CBS using a cerebrospinal fluid α-synuclein SAA, and in PSP this may impact on clinical course. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
背景种子扩增检测(SAA)已被开发为诊断α-突触核蛋白相关神经退行性疾病的生物标记物。目的本研究旨在评估进行性核上性麻痹(PSP)和皮质基底综合征(CBS)中α-突触核蛋白SAA阳性率,并分析SAA阳性和阴性病例的临床和病理特征。结果59例PSP病例中有6例(10.2%)α-突触核蛋白SAA阳性,其中1例为MSA型阳性。一项探索性分析显示,与 SAA 阴性病例相比,帕金森病型阳性的 PSP 病例年龄更大,病程更短。结论我们的研究结果表明,使用脑脊液α-突触核蛋白SAA可检测出PSP和CBS中的α-突触核蛋白种子,这可能会对PSP的临床病程产生影响。© 2024 作者。运动障碍》由 Wiley Periodicals LLC 代表国际帕金森和运动障碍协会出版。
{"title":"Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome.","authors":"David P Vaughan,Riona Fumi,Marte Theilmann Jensen,Megan Hodgson,Tatiana Georgiades,Lesley Wu,Danielle Lux,Ruth Obrocki,Jennifer Lamoureux,Olaf Ansorge,Kieren S J Allinson,Thomas T Warner,Zane Jaunmuktane,Anjum Misbahuddin,P Nigel Leigh,Boyd C P Ghosh,Kailash P Bhatia,Alistair Church,Christopher Kobylecki,Michele T M Hu,James B Rowe,Cornelis Blauwendraat,Huw R Morris,Edwin Jabbari","doi":"10.1002/mds.30019","DOIUrl":"https://doi.org/10.1002/mds.30019","url":null,"abstract":"BACKGROUNDSeed amplification assay (SAA) testing has been developed as a biomarker for the diagnosis of α-synuclein-related neurodegenerative disorders.OBJECTIVEThe objective of this study was to assess the rate of α-synuclein SAA positivity in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) and to analyze clinical and pathological features of SAA-positive and -negative cases.METHODSA total of 96 cerebrospinal fluid samples from clinically diagnosed PSP (n = 59) and CBS (n = 37) cases were analyzed using α-synuclein SAA.RESULTSSix of 59 (10.2%) PSP cases were α-synuclein SAA positive, including one case who was MSA-type positive. An exploratory analysis showed that PSP cases who were Parkinson's disease-type positive were older and had a shorter disease duration compared with SAA-negative cases. In contrast, 11 of 37 (29.7%) CBS cases were α-synuclein SAA positive, including two cases who were MSA-type positive.CONCLUSIONSOur results suggest that α-synuclein seeds can be detected in PSP and CBS using a cerebrospinal fluid α-synuclein SAA, and in PSP this may impact on clinical course. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"213 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142273469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RAB32 Variants in a German Parkinson's Disease Cohort 德国帕金森病队列中的 RAB32 变异
IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-19 DOI: 10.1002/mds.30005
Carolin Gabbert MSc, Cholpon Shambetova MD, Christoph Much, Joanne Trinh PhD, Christine Klein MD
{"title":"RAB32 Variants in a German Parkinson's Disease Cohort","authors":"Carolin Gabbert MSc,&nbsp;Cholpon Shambetova MD,&nbsp;Christoph Much,&nbsp;Joanne Trinh PhD,&nbsp;Christine Klein MD","doi":"10.1002/mds.30005","DOIUrl":"10.1002/mds.30005","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"39 11","pages":"2121-2123"},"PeriodicalIF":7.4,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mds.30005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142275596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pilot Group Cognitive Behavioral Therapy Telehealth Intervention for Functional Movement Disorder. 针对功能性运动障碍的试点小组认知行为疗法远程保健干预。
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-09-18 DOI: 10.1002/mds.30021
Vera N Kulikov,Dodie A Gillett,Carine W Maurer
{"title":"A Pilot Group Cognitive Behavioral Therapy Telehealth Intervention for Functional Movement Disorder.","authors":"Vera N Kulikov,Dodie A Gillett,Carine W Maurer","doi":"10.1002/mds.30021","DOIUrl":"https://doi.org/10.1002/mds.30021","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"197 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142245456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Movement Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1